Genmab Total Assets 2019-2022 | GMAB

Genmab total assets from 2019 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Genmab total assets for the quarter ending March 31, 2022 were $3.757B, a 4.35% increase year-over-year.
  • Genmab total assets for 2021 were $3.918B, a 20.96% increase from 2020.
  • Genmab total assets for 2020 were $3.239B, a 42.69% increase from 2019.
  • Genmab total assets for 2019 were $2.27B, a 69.38% increase from 2018.
Genmab Annual Total Assets
(Millions of US $)
2021 $3,918
2020 $3,239
2019 $2,270
2018 $1,340
Genmab Quarterly Total Assets
(Millions of US $)
2022-03-31 $3,757
2021-12-31 $3,918
2021-09-30 $3,804
2021-06-30 $3,644
2021-03-31 $3,600
2020-12-31 $3,239
2020-09-30 $3,379
2020-06-30 $3,055
2020-03-31 $2,260
2019-12-31 $2,270
2019-09-30 $1,986
2019-06-30 $1,352
2019-03-31 $0
2018-12-31 $1,340
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $19.273B $1.349B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.383B 9.82
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.475B 16.53
Biohaven Pharmaceutical Holding (BHVN) United States $9.944B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.681B 0.00
Emergent Biosolutions (EBS) United States $1.444B 6.18
Arcus Biosciences (RCUS) United States $1.389B 35.22
Myovant Sciences (MYOV) United Kingdom $0.879B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.509B 0.00
Gelesis Holdings (GLS) United States $0.362B 0.00
Zymeworks (ZYME) Canada $0.321B 0.00
Ambrx Biopharma (AMAM) United States $0.159B 0.00
Enzo Biochem (ENZ) United States $0.114B 23.50
SQZ Biotechnologies (SQZ) United States $0.093B 0.00